SlideShare a Scribd company logo
HEPATITIS
SHISODIA HARSHVARDHAN SINGH
UNIVERSITY OF PERPETUAL HELP SYSTEM DALTA
 Hepatitis is an inflammation of the liver .
 Viruses cause most cases of hepatitis .
 TYPE OF HEPATITIS –
- Hepatitis A
- Hepatitis B
- Hepatitis C
INTRODUCTION
INTRODUCTION
 Drug or alcohol use can also cause hepatitis .
 In other cases, your body mistakenly attacks healthy
cells in the liver .
 Some forms of hepatitis are mild, and others can be
serious. Some can lead to scarring, called cirrhosis, or
to liver cancer .
INTRODUCTION
 Some people who have hepatitis have no symptoms.
Others may have –
- Loss of appetite
- Nausea and vomiting
- Diarrhea
- Dark-colored urine and pale bowel movement
- Jaundice, yellowing of skin and eyes
INTRODUCTION
 Hepatitis B is a deadly disease with a high prevalence rate
in the Philippines.
 Studies show that in the Philippines there is a Hepatitis B
carrier rate of 9%.
 This means that out of 10 people at least 1 is a carrier of
Hepatitis B.
 It is estimated that more than 7.7 million people are
chronically infected with Hepatitis B, of whom between 1.1
and 1.9 million are expected to die prematurely of cirrhosis
or liver cancer..
PROGRAMM
 Chronic hepatitis B one of the most challenging
infectious diseases to manage.
 The Hepatology Society of the Philippines (HSP) has
seen the growing rate of Hepatitis B in the country
and aims to provide comprehensive information to
the public and medical community.
 They strive to spread awareness of Hepatitis B in the
country as well as providing the information and
means to the treatments necessary for the disease.
PROGRAM
 Every year, there are an estimated 20 million HEV
infections worldwide, leading to an estimated 3.3
million symptomatic cases of hepatitis E (1).
 WHO estimates that hepatitis E caused
approximately 44 000 deaths in 2015 (accounting for
3.3% of the mortality due to viral hepatitis).
OBJECT
 The virus is transmitted via the fecal-oral route,
principally via contaminated water.
 Hepatitis E is found worldwide, but the disease is
most common in East and South Asia.
 A vaccine to prevent hepatitis E virus infection has
been developed and is licensed in China, but is not
yet available elsewhere.
OBJECT
 3.5 million people are estimated to be living with
hepatitis C in the United States. The actual number
may be as high as 4.7 million or as low as 2.5 million.1
 850,000 people in the U.S. are estimated to be living
with hepatitis B. The actual number may be as high as
2.2 million or as low as 730,000.2
DATA SOURCE
 More than half of persons living with hepatitis do not
know that they have the virus. Thus, they are at risk
for life threatening liver disease and cancer and
unknowingly transmitting the virus to others.
 67% of persons living with hepatitis B infection do not
know they have the virus.
 51% of persons living with hepatitis C infection do not
know they have the virus.
DATA SOURCE
 Three out of four people living with hepatitis C infection
are baby boomers born between 1945 and 1965.
 Asian Americans and Pacific Islanders are the racial/ethnic
group that is most heavily affected by hepatitis B virus.
Asians and Pacific Islanders represent about 5% of the U.S.
population, but they represent about half of all persons
living with hepatitis B. As a result, 1 in 12 Asian Americans
and Pacific Islanders are living with hepatitis B.
DATA SOURCE
 Hepatitis C infections are increasing in the United
States.
DATA SOURCE
 Acute hepatitis C infections increased 364% from 2006
to 2012 in four states affected by the opioid epidemic
(Kentucky, Tennessee, Virginia, West Virginia).
Acute hepatitis B infections increased 114% from
2006 to 2013 in three states affected by the opioid
epidemic (Kentucky, Tennessee, West Virginia).
DATA SOURCE
 The CDC recommends the hepatitis A vaccine for all
children beginning at age one, as well as for those
who have not been previously immunized and are at
high risk for contracting the disease .
 For children 12 months of age or older, the
vaccination is given as a shot into the muscle in two
doses 6–18 months apart and should be started
before the age 24 months.
PLAN
 The CDC recommends the routine vaccination of all
children under the age of 19 with the hepatitis B
vaccine.
 They also recommend it for those who desire it or are
at high risk.
PLAN
Hepatitis A B C

More Related Content

What's hot (20)

Hepatitis A Virus (HAV).pptx
Hepatitis A Virus (HAV).pptxHepatitis A Virus (HAV).pptx
Hepatitis A Virus (HAV).pptx
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Hepatitis D
Hepatitis DHepatitis D
Hepatitis D
 
Hepatitis-B
Hepatitis-BHepatitis-B
Hepatitis-B
 
CHOLERA - Acute diarrhoeal disease
CHOLERA - Acute diarrhoeal diseaseCHOLERA - Acute diarrhoeal disease
CHOLERA - Acute diarrhoeal disease
 
Hepatitis E Virus
Hepatitis E VirusHepatitis E Virus
Hepatitis E Virus
 
Vibrio cholera
Vibrio choleraVibrio cholera
Vibrio cholera
 
HEPATITIS D
HEPATITIS DHEPATITIS D
HEPATITIS D
 
Hepatitis D
Hepatitis DHepatitis D
Hepatitis D
 
Viral hepatitis
Viral hepatitisViral hepatitis
Viral hepatitis
 
Viral hepatitis a+e
Viral hepatitis a+eViral hepatitis a+e
Viral hepatitis a+e
 
HEPATITIS C VIRUS
HEPATITIS C VIRUSHEPATITIS C VIRUS
HEPATITIS C VIRUS
 
Viral Hepatitis
Viral HepatitisViral Hepatitis
Viral Hepatitis
 
Hepatitis b (hbv)
Hepatitis b (hbv)Hepatitis b (hbv)
Hepatitis b (hbv)
 
Hepatitis c
Hepatitis cHepatitis c
Hepatitis c
 
Hepatitis ppt
Hepatitis pptHepatitis ppt
Hepatitis ppt
 
Hepatitis E infection
Hepatitis E infectionHepatitis E infection
Hepatitis E infection
 
Hepatitis a, e, b
Hepatitis a, e, bHepatitis a, e, b
Hepatitis a, e, b
 
HCV- Hepatitis and Hepatitis C Infection
HCV- Hepatitis and Hepatitis C InfectionHCV- Hepatitis and Hepatitis C Infection
HCV- Hepatitis and Hepatitis C Infection
 

Similar to Hepatitis A B C

world hepatitis day awareness presentation july 2022.pptx
world hepatitis day awareness presentation july 2022.pptxworld hepatitis day awareness presentation july 2022.pptx
world hepatitis day awareness presentation july 2022.pptxanjalatchi
 
What Is Hepatistis St E. Transition
What Is Hepatistis  St E. TransitionWhat Is Hepatistis  St E. Transition
What Is Hepatistis St E. Transitionwillow45
 
Assignment of research.docx
Assignment of research.docxAssignment of research.docx
Assignment of research.docxSamafalechannel
 
Hepatitis06 16 09
Hepatitis06 16 09Hepatitis06 16 09
Hepatitis06 16 09PVHaleJr
 
Hepatitis B and C.pptx
Hepatitis B and C.pptxHepatitis B and C.pptx
Hepatitis B and C.pptxAabidMir10
 
Physician's Guide
Physician's GuidePhysician's Guide
Physician's GuideElyshaTsai
 
Hepatitis-B: A Case Study
Hepatitis-B: A Case StudyHepatitis-B: A Case Study
Hepatitis-B: A Case StudyLashhkaraa
 
Hepatitis b disease surveilance :epidemiology:school of public health: univer...
Hepatitis b disease surveilance :epidemiology:school of public health: univer...Hepatitis b disease surveilance :epidemiology:school of public health: univer...
Hepatitis b disease surveilance :epidemiology:school of public health: univer...Salwa Rashid
 
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014Will Zasadny
 
Hepatitis Presentation
Hepatitis PresentationHepatitis Presentation
Hepatitis Presentationd.santiago
 
Hepatitis Power Point
Hepatitis  Power  PointHepatitis  Power  Point
Hepatitis Power PointKassandra.J
 
world hepatitis day [ my work ].pptx
world hepatitis day [ my work ].pptxworld hepatitis day [ my work ].pptx
world hepatitis day [ my work ].pptxKhushi292056
 
Presentation to the WA Joint Conference on Health 2010
Presentation to the WA Joint Conference on Health 2010Presentation to the WA Joint Conference on Health 2010
Presentation to the WA Joint Conference on Health 2010Hepatitis Education Project
 

Similar to Hepatitis A B C (20)

world hepatitis day awareness presentation july 2022.pptx
world hepatitis day awareness presentation july 2022.pptxworld hepatitis day awareness presentation july 2022.pptx
world hepatitis day awareness presentation july 2022.pptx
 
Hepatitis day,2021
Hepatitis day,2021Hepatitis day,2021
Hepatitis day,2021
 
What Is Hepatistis St E. Transition
What Is Hepatistis  St E. TransitionWhat Is Hepatistis  St E. Transition
What Is Hepatistis St E. Transition
 
Assignment of research.docx
Assignment of research.docxAssignment of research.docx
Assignment of research.docx
 
World Hepatitis Day
World Hepatitis DayWorld Hepatitis Day
World Hepatitis Day
 
hepatitis day post.pptx
hepatitis day post.pptxhepatitis day post.pptx
hepatitis day post.pptx
 
Hepatitis a
Hepatitis aHepatitis a
Hepatitis a
 
Hepatitis06 16 09
Hepatitis06 16 09Hepatitis06 16 09
Hepatitis06 16 09
 
Hepatitis a final
Hepatitis a finalHepatitis a final
Hepatitis a final
 
Hepatitis B and C.pptx
Hepatitis B and C.pptxHepatitis B and C.pptx
Hepatitis B and C.pptx
 
Physician's Guide
Physician's GuidePhysician's Guide
Physician's Guide
 
Hepatitis-B: A Case Study
Hepatitis-B: A Case StudyHepatitis-B: A Case Study
Hepatitis-B: A Case Study
 
Hepatitis b disease surveilance :epidemiology:school of public health: univer...
Hepatitis b disease surveilance :epidemiology:school of public health: univer...Hepatitis b disease surveilance :epidemiology:school of public health: univer...
Hepatitis b disease surveilance :epidemiology:school of public health: univer...
 
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
FINAL-CHI-Report-Innovation-in-Hepatitis-C-Treatment-July-2014
 
Hepatitis C virus
Hepatitis C virus Hepatitis C virus
Hepatitis C virus
 
hepatitis
hepatitishepatitis
hepatitis
 
Hepatitis Presentation
Hepatitis PresentationHepatitis Presentation
Hepatitis Presentation
 
Hepatitis Power Point
Hepatitis  Power  PointHepatitis  Power  Point
Hepatitis Power Point
 
world hepatitis day [ my work ].pptx
world hepatitis day [ my work ].pptxworld hepatitis day [ my work ].pptx
world hepatitis day [ my work ].pptx
 
Presentation to the WA Joint Conference on Health 2010
Presentation to the WA Joint Conference on Health 2010Presentation to the WA Joint Conference on Health 2010
Presentation to the WA Joint Conference on Health 2010
 

More from UNIVERSITY OF PERPETUAL HELP SYSTEM (8)

Nephrolithiasis_SHISODIA.pptx.pptx
Nephrolithiasis_SHISODIA.pptx.pptxNephrolithiasis_SHISODIA.pptx.pptx
Nephrolithiasis_SHISODIA.pptx.pptx
 
Complete history taking _SHISODIA.pptx.pptx
Complete history taking _SHISODIA.pptx.pptxComplete history taking _SHISODIA.pptx.pptx
Complete history taking _SHISODIA.pptx.pptx
 
Case Study MALARIA
Case Study MALARIA Case Study MALARIA
Case Study MALARIA
 
Associative organ digestive tract
Associative organ digestive tractAssociative organ digestive tract
Associative organ digestive tract
 
physiologic anatomy of liver
physiologic anatomy of liverphysiologic anatomy of liver
physiologic anatomy of liver
 
Digestive tract ppt
Digestive tract pptDigestive tract ppt
Digestive tract ppt
 
Hepatitis
HepatitisHepatitis
Hepatitis
 
about water and ph , protin and heamoglobi etc.
about water and ph , protin and heamoglobi etc.about water and ph , protin and heamoglobi etc.
about water and ph , protin and heamoglobi etc.
 

Recently uploaded

Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxgauripg8
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthCatherine Liao
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingMedicoseAcademics
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Catherine Liao
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghanahealthwatchghana
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Catherine Liao
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Catherine Liao
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentabdeli bhadarva
 
5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341Sherrylee83
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1DR SETH JOTHAM
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyDr KHALID B.M
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionGolden Helix
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...kevinkariuki227
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxSergio Pinski
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feeldranji1
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Catherine Liao
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communicationskatiequigley33
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfDr Jeenal Mistry
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...Catherine Liao
 

Recently uploaded (20)

Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...Arterial health throughout cancer treatment and exercise rehabilitation in wo...
Arterial health throughout cancer treatment and exercise rehabilitation in wo...
 
Anuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatmentAnuman- An inference for helpful in diagnosis and treatment
Anuman- An inference for helpful in diagnosis and treatment
 
5cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +852975043415cl adbb 5cladba cheap and fine Telegram: +85297504341
5cl adbb 5cladba cheap and fine Telegram: +85297504341
 
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
THORACOTOMY . SURGICAL PERSPECTIVES VOL 1
 
Aptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal TestimonyAptopadesha Pramana / Pariksha: The Verbal Testimony
Aptopadesha Pramana / Pariksha: The Verbal Testimony
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
A thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptxA thorough review of supernormal conduction.pptx
A thorough review of supernormal conduction.pptx
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
End Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feelEnd Feel -joint end feel - Normal and Abnormal end feel
End Feel -joint end feel - Normal and Abnormal end feel
 
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
Is preeclampsia and spontaneous preterm delivery associate with vascular and ...
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 

Hepatitis A B C

  • 1. HEPATITIS SHISODIA HARSHVARDHAN SINGH UNIVERSITY OF PERPETUAL HELP SYSTEM DALTA
  • 2.  Hepatitis is an inflammation of the liver .  Viruses cause most cases of hepatitis .  TYPE OF HEPATITIS – - Hepatitis A - Hepatitis B - Hepatitis C INTRODUCTION
  • 4.  Drug or alcohol use can also cause hepatitis .  In other cases, your body mistakenly attacks healthy cells in the liver .  Some forms of hepatitis are mild, and others can be serious. Some can lead to scarring, called cirrhosis, or to liver cancer . INTRODUCTION
  • 5.  Some people who have hepatitis have no symptoms. Others may have – - Loss of appetite - Nausea and vomiting - Diarrhea - Dark-colored urine and pale bowel movement - Jaundice, yellowing of skin and eyes INTRODUCTION
  • 6.  Hepatitis B is a deadly disease with a high prevalence rate in the Philippines.  Studies show that in the Philippines there is a Hepatitis B carrier rate of 9%.  This means that out of 10 people at least 1 is a carrier of Hepatitis B.  It is estimated that more than 7.7 million people are chronically infected with Hepatitis B, of whom between 1.1 and 1.9 million are expected to die prematurely of cirrhosis or liver cancer.. PROGRAMM
  • 7.  Chronic hepatitis B one of the most challenging infectious diseases to manage.  The Hepatology Society of the Philippines (HSP) has seen the growing rate of Hepatitis B in the country and aims to provide comprehensive information to the public and medical community.
  • 8.  They strive to spread awareness of Hepatitis B in the country as well as providing the information and means to the treatments necessary for the disease. PROGRAM
  • 9.  Every year, there are an estimated 20 million HEV infections worldwide, leading to an estimated 3.3 million symptomatic cases of hepatitis E (1).  WHO estimates that hepatitis E caused approximately 44 000 deaths in 2015 (accounting for 3.3% of the mortality due to viral hepatitis). OBJECT
  • 10.  The virus is transmitted via the fecal-oral route, principally via contaminated water.  Hepatitis E is found worldwide, but the disease is most common in East and South Asia.  A vaccine to prevent hepatitis E virus infection has been developed and is licensed in China, but is not yet available elsewhere. OBJECT
  • 11.  3.5 million people are estimated to be living with hepatitis C in the United States. The actual number may be as high as 4.7 million or as low as 2.5 million.1  850,000 people in the U.S. are estimated to be living with hepatitis B. The actual number may be as high as 2.2 million or as low as 730,000.2 DATA SOURCE
  • 12.  More than half of persons living with hepatitis do not know that they have the virus. Thus, they are at risk for life threatening liver disease and cancer and unknowingly transmitting the virus to others.  67% of persons living with hepatitis B infection do not know they have the virus.  51% of persons living with hepatitis C infection do not know they have the virus. DATA SOURCE
  • 13.  Three out of four people living with hepatitis C infection are baby boomers born between 1945 and 1965.  Asian Americans and Pacific Islanders are the racial/ethnic group that is most heavily affected by hepatitis B virus. Asians and Pacific Islanders represent about 5% of the U.S. population, but they represent about half of all persons living with hepatitis B. As a result, 1 in 12 Asian Americans and Pacific Islanders are living with hepatitis B. DATA SOURCE
  • 14.  Hepatitis C infections are increasing in the United States. DATA SOURCE
  • 15.  Acute hepatitis C infections increased 364% from 2006 to 2012 in four states affected by the opioid epidemic (Kentucky, Tennessee, Virginia, West Virginia). Acute hepatitis B infections increased 114% from 2006 to 2013 in three states affected by the opioid epidemic (Kentucky, Tennessee, West Virginia). DATA SOURCE
  • 16.  The CDC recommends the hepatitis A vaccine for all children beginning at age one, as well as for those who have not been previously immunized and are at high risk for contracting the disease .  For children 12 months of age or older, the vaccination is given as a shot into the muscle in two doses 6–18 months apart and should be started before the age 24 months. PLAN
  • 17.  The CDC recommends the routine vaccination of all children under the age of 19 with the hepatitis B vaccine.  They also recommend it for those who desire it or are at high risk. PLAN